565 related items for PubMed ID: 28301972
1. Efficacy of transsphenoidal surgery in achieving biochemical cure of growth hormone-secreting pituitary adenomas among patients with cavernous sinus invasion: a systematic review and meta-analysis.
Briceno V, Zaidi HA, Doucette JA, Onomichi KB, Alreshidi A, Mekary RA, Smith TR.
Neurol Res; 2017 May; 39(5):387-398. PubMed ID: 28301972
[Abstract] [Full Text] [Related]
2. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[Abstract] [Full Text] [Related]
3. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
Park HH, Kim EH, Ku CR, Lee EJ, Kim SH.
World Neurosurg; 2018 Sep; 117():e280-e289. PubMed ID: 29906579
[Abstract] [Full Text] [Related]
4. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.
Nishioka H, Fukuhara N, Horiguchi K, Yamada S.
J Neurosurg; 2014 Sep; 121(3):505-10. PubMed ID: 25014437
[Abstract] [Full Text] [Related]
5. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[Abstract] [Full Text] [Related]
6. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[Abstract] [Full Text] [Related]
7. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[Abstract] [Full Text] [Related]
8. Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
Ceylan S, Koc K, Anik I.
J Neurosurg; 2010 Jan; 112(1):99-107. PubMed ID: 19480546
[Abstract] [Full Text] [Related]
9. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[Abstract] [Full Text] [Related]
10. Cavernous sinus invasion and effect of immunohistochemical features on remission in growth hormone secreting pituitary adenomas.
Yilmaz M, Vural E, Koc K, Ceylan S.
Turk Neurosurg; 2015 Oct; 25(3):380-8. PubMed ID: 26037177
[Abstract] [Full Text] [Related]
11. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[Abstract] [Full Text] [Related]
12. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M, Motiei-Langroudi R.
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[Abstract] [Full Text] [Related]
13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
14. [Transsphenoidal surgery of secretory and invasive pituitary adenomas (somatotropinoma or corticotropinoma)--own experiences].
Zieliński G, Podgórski JK, Koziarski A, Potakiewicz Z, Warczyńska A, Zgliczyński W, Makowska A.
Przegl Lek; 2004 Dec; 61(9):928-34. PubMed ID: 15803901
[Abstract] [Full Text] [Related]
15. Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone-Secreting Pituitary Adenomas-Systematic Review and Meta-Analysis.
Phan K, Xu J, Reddy R, Kalakoti P, Nanda A, Fairhall J.
World Neurosurg; 2017 Jan; 97():398-406. PubMed ID: 27756664
[Abstract] [Full Text] [Related]
16. A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission.
Unal TC, Aydoseli A, Ozgen U, Dolas I, Sabanci PA, Aras Y, Ozturk M, Ozata MS, Gul N, Kubat Uzum A, Mutlu U, Bilgic B, Saka E, Yarman S, Sencer A.
Br J Neurosurg; 2024 Jun; 38(3):648-653. PubMed ID: 34241568
[Abstract] [Full Text] [Related]
17. Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly.
Kim JH, Hur KY, Lee JH, Lee JH, Se YB, Kim HI, Lee SH, Nam DH, Kim SY, Kim KW, Kong DS, Kim YH.
World Neurosurg; 2017 Aug; 104():272-278. PubMed ID: 28465267
[Abstract] [Full Text] [Related]
18. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C, Oearsakul T.
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[Abstract] [Full Text] [Related]
19. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[Abstract] [Full Text] [Related]
20. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
Juraschka K, Khan OH, Godoy BL, Monsalves E, Kilian A, Krischek B, Ghare A, Vescan A, Gentili F, Zadeh G.
J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
